Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,333 | 3,769 | 5,943 | 10,970 | 790 |
| Marketable Securities | 13,189 | 14,304 | 15,729 | 15,202 | 5,019 |
| Receivables | 75 | 75 | 75 | 75 | 1,519 |
| TOTAL | $16,206 | $18,891 | $22,354 | $26,612 | $7,648 |
| Non-Current Assets | |||||
| PPE Net | 958 | 953 | 1,020 | 1,095 | 1,164 |
| Other Non-Current Assets | 87 | 105 | 122 | 139 | 157 |
| TOTAL | $1,045 | $1,058 | $1,142 | $1,234 | $1,321 |
| Total Assets | $17,251 | $19,949 | $23,496 | $27,846 | $8,969 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 772 | 357 | 147 | 388 | 614 |
| Accrued Expenses | 3,420 | 1,264 | 1,314 | 1,065 | 2,152 |
| TOTAL | $4,192 | $2,420 | $2,301 | $2,218 | $2,766 |
| Non-Current Liabilities | |||||
| TOTAL | $1,000 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,192 | $2,420 | $2,301 | $2,218 | $2,766 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 318 | 318 | 317 | 317 | 316 |
| Common Shares | 64 | 99,651 | 99,533 | 99,404 | 253 |
| Retained earnings | -87,763 | -82,097 | -78,280 | -73,731 | -93,029 |
| Other shareholders' equity | -13 | -25 | -58 | -45 | -16 |
| TOTAL | $12,059 | $17,529 | $21,195 | $25,628 | $6,203 |
| Total Liabilities And Equity | $17,251 | $19,949 | $23,496 | $27,846 | $8,969 |